Brind.

Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.

1 report, 1 independent Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Atlas Venture

    American early-stage venture capital firm

    Nothing else this week.

  • OrbiMed

    Investment service in New York City, New York

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Business WireRenasant Bio Launches to Pioneer Next-Generation Disease-Modifying Small Molecule Treatments for ADPKD Advancing corrector and potentiator programs to address underlying biology of autosomal dominant